These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children. Bright-Thomas R; Nandwani S; Smith J; Morris JA; Ormerod LP Arch Dis Child; 2010 Aug; 95(8):600-2. PubMed ID: 20530147 [TBL] [Abstract][Full Text] [Related]
5. Role of individual drugs in the chemotherapy of tuberculosis. Mitchison DA Int J Tuberc Lung Dis; 2000 Sep; 4(9):796-806. PubMed ID: 10985648 [TBL] [Abstract][Full Text] [Related]
6. Gatifloxacin in combination with rifampicin in a murine tuberculosis model. Cynamon M; Sklaney MR; Shoen C J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504 [TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of chemotherapy of intrathoracic tuberculosis in children: late follow-up data]. Iukhimenko NV Probl Tuberk; 2001; (5):19-22. PubMed ID: 11588952 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of tuberculosis. Pinsker KL; Koerner SK Am J Hosp Pharm; 1976 Mar; 33(3):275-83. PubMed ID: 769544 [TBL] [Abstract][Full Text] [Related]
9. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398 [TBL] [Abstract][Full Text] [Related]
10. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India. Shah AR; Agarwal SK; Shah KV Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118 [TBL] [Abstract][Full Text] [Related]
11. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. Reichman LB; Lardizabal A; Hayden CH Am J Respir Crit Care Med; 2004 Oct; 170(8):832-5. PubMed ID: 15297274 [No Abstract] [Full Text] [Related]
12. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755 [TBL] [Abstract][Full Text] [Related]
13. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)]. Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898 [TBL] [Abstract][Full Text] [Related]
14. An ounce of tuberculosis prevention. Kornfeld H Chest; 2008 Apr; 133(4):835-6. PubMed ID: 18398110 [No Abstract] [Full Text] [Related]
15. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues. Skevaki CL; Kafetzis DA Paediatr Drugs; 2005; 7(4):219-34. PubMed ID: 16117559 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia. Mwinga A; Hosp M; Zulu I; Farthing MJ; Mulambo S; Kelly P AIDS; 2002 Mar; 16(5):806-8. PubMed ID: 11964547 [No Abstract] [Full Text] [Related]
17. Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Halsey NA; Coberly JS; Desormeaux J; Losikoff P; Atkinson J; Moulton LH; Contave M; Johnson M; Davis H; Geiter L; Johnson E; Huebner R; Boulos R; Chaisson RE Lancet; 1998 Mar; 351(9105):786-92. PubMed ID: 9519950 [TBL] [Abstract][Full Text] [Related]
18. [Considerations about the efficiency of treatment regimens with fixed Rifampicin-Isoniazid combinations in pulmonary tuberculosis]. Munteanu I; Husar I; Didilescu C; Stoicescu IP Pneumologia; 2004; 53(1):23-5. PubMed ID: 18210717 [TBL] [Abstract][Full Text] [Related]